JURNISTA hydromorphone hydrochloride 16 mg prolonged release tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

jurnista hydromorphone hydrochloride 16 mg prolonged release tablet blister pack

janssen-cilag pty ltd - hydromorphone hydrochloride, quantity: 16 mg - tablet, modified release - excipient ingredients: polyethylene oxide; povidone; magnesium stearate; butylated hydroxytoluene; sodium chloride; iron oxide black; cellulose acetate; hypromellose; lactose; macrogol 3350; lactose monohydrate; titanium dioxide; triacetin; iron oxide yellow; macrogol 400; propylene glycol; isopropyl alcohol; purified water - jurnista is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. jurnista is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. jurnista is not indicated as an as-needed (prn) analgesia. not for use in opioid na?ve patients.

JURNISTA hydromorphone hydrochloride 8 mg prolonged release tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

jurnista hydromorphone hydrochloride 8 mg prolonged release tablet blister pack

janssen-cilag pty ltd - hydromorphone hydrochloride, quantity: 8 mg - tablet, modified release - excipient ingredients: polyethylene oxide; povidone; magnesium stearate; butylated hydroxytoluene; sodium chloride; iron oxide black; cellulose acetate; hypromellose; lactose; macrogol 3350; lactose monohydrate; titanium dioxide; triacetin; iron oxide red; macrogol 400; propylene glycol; isopropyl alcohol; purified water - jurnista is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. jurnista is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. jurnista is not indicated as an as-needed (prn) analgesia. not for use in opioid na?ve patients.

STEMETIL prochlorperazine maleate 5mg tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

stemetil prochlorperazine maleate 5mg tablet blister pack

sanofi-aventis australia pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium lauryl sulfate; calcium hydrogen phosphate dihydrate; wheat starch; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

ISORDIL 5mg tablet Australie - anglais - Department of Health (Therapeutic Goods Administration)

isordil 5mg tablet

arrow pharma pty ltd - isosorbide dinitrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; erythrosine; magnesium stearate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. conditions varied as approved in theletter of 3 april 1992 from dr bijoy varma. indicated for angina pectoris and management of congestive heart failure. indications as at 23 may 2005 : treatment of angina pectoris (classic effort associated angina, chronic stable angina, vaso-spastic angina, variant angina, unstable angina and angina decubitus) and myocardial ischaemia due to ischaemic heart disease, and an aid in the management of left ventricular failure, either alone or as part of the syndrome of congestive heart failure. sublingual - prevention and treatment of angina pectoris and myocardial ischaemia due to ischaemic heart disease. acute and chronic left ventricular failure, either alone or as part of the syndrome of congestive heart failure to improve cardiac performance and stabilise the patient's condition.

PARACETAMOL SANDOZ PHARMA paracetamol 500 mg tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

paracetamol sandoz pharma paracetamol 500 mg tablet blister pack

sandoz pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: purified talc; sodium metabisulfite; colloidal anhydrous silica; sodium lauryl sulfate; sodium starch glycollate; magnesium stearate; maize starch; povidone - temporary relief of pain. reduces fever.

WAGNER HEALTH PARACETAMOL 500 mg tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

wagner health paracetamol 500 mg tablet blister pack

sandoz pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; povidone; colloidal anhydrous silica; purified talc; sodium lauryl sulfate; sodium metabisulfite; maize starch - temporary relief of pain. reduces fever.

HELP@HAND FOR PAIN RELIEF PARACETAMOL 500 mg capsule-shaped tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

help@hand for pain relief paracetamol 500 mg capsule-shaped tablet bottle

nova pharmaceuticals australasia pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; magnesium stearate; sodium metabisulfite - for temporary relief of pain and discomfort associated with: headaches, muscular aches, toothache, arthritic pain, migraine headache, symptoms of cold and flu, period pain, rheumatics and tension headache. reduces fever.

PRICELINE PARACETAMOL 500 mg tablet blister pack (formulation 3) Australie - anglais - Department of Health (Therapeutic Goods Administration)

priceline paracetamol 500 mg tablet blister pack (formulation 3)

noumed pharmaceuticals pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; sodium starch glycollate; sodium metabisulfite; colloidal anhydrous silica; povidone; maize starch; purified talc - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

PHARMACY HEALTH PARACETAMOL 500 mg tablet blister pack (formulation 5) Australie - anglais - Department of Health (Therapeutic Goods Administration)

pharmacy health paracetamol 500 mg tablet blister pack (formulation 5)

noumed pharmaceuticals pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: purified talc; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate; povidone; sodium metabisulfite; sodium lauryl sulfate; maize starch - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

TERRYWHITE CHEMMART PARACETAMOL 500 mg tablet blister pack (formulation 3) Australie - anglais - Department of Health (Therapeutic Goods Administration)

terrywhite chemmart paracetamol 500 mg tablet blister pack (formulation 3)

noumed pharmaceuticals pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; sodium lauryl sulfate; purified talc; sodium metabisulfite; magnesium stearate; sodium starch glycollate; colloidal anhydrous silica - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.